Authors: Erman, M Akova, M Akan, H Korten, V Ferhanoglu, B Koksal, I Cetinkaya, Y Uzun, O Unal, S

Citation: M. Erman et al., Comparison of cefepime and ceftazidime in combination with amikacin in theempirical treatment of high-risk patients with febrile neutropenia: A prospective, randomized, multicenter study, SC J IN DIS, 33(11), 2001, pp. 827-831

Authors: Vahaboglu, H Coskunkan, F Tansel, O Ozturk, R Sahin, N Koksal, I Kocazeybek, B Tatman-Otkun, M Leblebicioglu, H Ozinel, MA Akalin, H Kocagoz, S Korten, V

Citation: H. Vahaboglu et al., Clinical importance of extended-spectrum beta-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strains, J MED MICRO, 50(7), 2001, pp. 642-645

Authors: Mogulkoc, N Karakurt, S Isalska, B Bayindir, U Celikel, T Korten, V Colpan, N

Citation: N. Mogulkoc et al., Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection, AM J R CRIT, 160(1), 1999, pp. 349-353

Authors: Akova, M Akan, H Korten, V Biberoglu, K Hayran, M Unal, S Kars, A Kansu, E

Citation: M. Akova et al., Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics, INT J ANT A, 13(1), 1999, pp. 15-19

Authors: Pfaller, MA Korten, V Jones, RN Doern, GV

Citation: Ma. Pfaller et al., Multicenter evaluation of the antimicrobial activity for seven broad-spectrum beta-lactams in Turkey using the Etest method, DIAG MICR I, 35(1), 1999, pp. 65-73